These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 30788009)
1. The Intersection of Diabetes and Cardiovascular Disease. Petak S; Sardhu A Methodist Debakey Cardiovasc J; 2018; 14(4):249-250. PubMed ID: 30788009 [No Abstract] [Full Text] [Related]
2. Improved outcomes from diabetes monitoring: the benefits of better adherence, therapy adjustments, patient education, and telemedicine support. Klonoff DC J Diabetes Sci Technol; 2012 May; 6(3):486-90. PubMed ID: 22768877 [No Abstract] [Full Text] [Related]
3. Back to glycemic control: An alternative look at the results of cardiovascular outcome trials in type 2 diabetes. Mannucci E; Monami M; Ceriello A; Rotella CM Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):375-377. PubMed ID: 28242233 [No Abstract] [Full Text] [Related]
4. Management of diabetes mellitus in the elderly. Chiniwala N; Jabbour S Curr Opin Endocrinol Diabetes Obes; 2011 Apr; 18(2):148-52. PubMed ID: 21522002 [TBL] [Abstract][Full Text] [Related]
5. Screening for diabetes in patients with cardiovascular disease: HbA1c trumps oral glucose tolerance testing. Sattar N; Preiss D Lancet Diabetes Endocrinol; 2016 Jul; 4(7):560-2. PubMed ID: 27039357 [No Abstract] [Full Text] [Related]
6. Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications. Sun B; Luo Z; Zhou J Cardiovasc Diabetol; 2021 Jan; 20(1):9. PubMed ID: 33413392 [TBL] [Abstract][Full Text] [Related]
7. Effects of Mobile Text Messaging on Glycemic Control in Patients With Coronary Heart Disease and Diabetes Mellitus: A Randomized Clinical Trial. Huo X; Krumholz HM; Bai X; Spatz ES; Ding Q; Horak P; Zhao W; Gong Q; Zhang H; Yan X; Sun Y; Liu J; Wu X; Guan W; Wang X; Li J; Li X; Spertus JA; Masoudi FA; Zheng X Circ Cardiovasc Qual Outcomes; 2019 Sep; 12(9):e005805. PubMed ID: 31474119 [TBL] [Abstract][Full Text] [Related]
8. Counterpoint: Intensive glucose control and mortality in ACCORD--still looking for clues. Riddle MC Diabetes Care; 2010 Dec; 33(12):2722-4. PubMed ID: 21115778 [No Abstract] [Full Text] [Related]
9. Decrease mortality in type II diabetes mellitus: glycemic and renal function control. Borghi C; Ventura F J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e13-e15. PubMed ID: 29538138 [No Abstract] [Full Text] [Related]
10. Is glycemic control a quinidine-like intervention? Bloomgarden ZT J Diabetes; 2014 Sep; 6(5):387-8. PubMed ID: 24842383 [No Abstract] [Full Text] [Related]
17. Point: Intensive glycemic control and mortality in ACCORD--a chance finding? Lachin JM Diabetes Care; 2010 Dec; 33(12):2719-21. PubMed ID: 21115777 [No Abstract] [Full Text] [Related]
18. Role of Purified Anthocyanins in Improving Cardiometabolic Risk Factors in Chinese Men and Women with Prediabetes or Early Untreated Diabetes-A Randomized Controlled Trial. Yang L; Ling W; Yang Y; Chen Y; Tian Z; Du Z; Chen J; Xie Y; Liu Z; Yang L Nutrients; 2017 Oct; 9(10):. PubMed ID: 28994705 [No Abstract] [Full Text] [Related]
19. Impact of pre-diabetes and diabetes on cardiovascular outcomes. Anselmino M; Sillano D Curr Vasc Pharmacol; 2012 Nov; 10(6):680-3. PubMed ID: 23259552 [TBL] [Abstract][Full Text] [Related]
20. Diabetes: Prevalence, prognosis and management of a potent cardiovascular risk factor. Norhammar A; Mellbin L; Cosentino F Eur J Prev Cardiol; 2017 Jun; 24(3_suppl):52-60. PubMed ID: 28618910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]